• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

New study lays groundwork for heartworm vaccine development

July 15, 2020
Sarah Mouton Dowdy
dvm360, dvm360 July 2020, Volume 51, Issue 7

With heartworm infections on the rise, researchers from the University of Liverpool have identified two immunosuppressive proteins in Dirofilaria immitis as potential targets for a novel vaccine.

Researchers from the University of Liverpool in the United Kingdom are working toward the development of a heartworm vaccine to combat the growing threat posed by the resistance of Dirofilaria immitis to macrocyclic lactones.

The American Heartworm Society (AHS) estimates that more than a million dogs in the U.S. have heartworm disease. And according to an analysis published in Parasites & Vectors in 2018, infection incidence is on the rise, with AHS reporting a 21.7% increase in average cases per clinic between 2013 and 2016. The analysis lists poor compliance with heartworm prevention guidelines (about two-thirds of dogs don’t receive any heartworm prevention) and emerging resistance to macrocyclic lactones as potential causes for the concerning upward trend.

Pinpointing immunosuppressive proteins

Advertisement

In pursuit of sustainable heartworm prevention, Ben Makepeace, PhD, the study’s principal investigator, and his team first looked at other filarial parasites similar to D. immitis — specifically, Litomosoides sigmodontis and Onchocerca ochengi — and were able to identify two common proteins in both parasite species that interfere with the host’s immune system, making them potential vaccine targets. One of the proteins blocks a pathway alerting the immune system to the parasites’ presence, and the other stops T cells from attacking the worms.

For the current study, which is backed by both AHS and the Morris Animal Foundation, Dr. Makepeace says they will incubate proteins from D. immitis that are equivalent to the ones identified above with white blood cells from healthy donor dogs to determine their effect on the immune response and to see if any of their immunosuppressive effects can be blocked. “This is an essential step before a clinical trial for a vaccine can be performed,” he adds.

An addition to your heartworm prevention toolbox

But even if Dr. Makepeace and his team reach their goal of a heartworm vaccine (a goal that’s suffered serious delays due to the coronavirus pandemic), they don’t see their work as completely cancelling out the need for preventive drugs and mosquito repellents. “It’s more about extending the life of the tools we have so we don’t reach the nightmare scenario of heartworm being unpreventable,” he explains.

download issueDownload Issue: dvm360 July 2020

Related Content:

ClinicalMedicalParasitologyAssociatesTechniciansRolesdvm360 July 2020
Can our Pride panel answer these LGBTQ+ trivia questions?
Can our Pride panel answer these LGBTQ+ trivia questions?
Creating inclusive spaces for the LGBTQ+ community in vet med
Creating inclusive spaces for the LGBTQ+ community in vet med
Happy Pride Month, Hill's launches Prescription Diet ONC Care, and more
Happy Pride Month, Hill's launches Prescription Diet ONC Care, and more

Advertisement

Latest News

News wrap-up: This week’s headlines, plus Kansas State University College of Veterinary Medicine presents Temple Grandin, PhD, MS, with an honorary degree

Can our Pride panel answer these LGBTQ+ trivia questions?

Creating inclusive spaces for the LGBTQ+ community in vet med

Happy Pride Month, Hill's launches Prescription Diet ONC Care, and more

View More Latest News
Advertisement